Twin Vaginal Breech Deliveries Before and After Starting Training Skills and Clinical Approach in Labor Ward (TVBD)

January 9, 2025 updated by: Claudio Celentano, G. d'Annunzio University

Twin Vaginal Deliveries and Maternal-fetal Outcomes Before and After Starting Training of Teamworks

In January 2021 Dept of ObGyn of Santo Spirito Hospital Pescara Italy, and in July 2022 Dept of ObGyn of San Giovanni di Dio Hospital Florence Italy, started regular training in management of obstetric emergencies. Twin vaginal deliveries were considered when first fetus is vertex presenting. The present study is evaluating retrospectively the rate of vaginal birth in twins after 34 weeks' gestation in the period 2017-2020, and 2021-2024 for Santo Spirito Hospital Pescara, and 2020-2022 June, and July 2022-2024 for San Giovanni di Dio Hospital Pescara. Incidence of maternal and fetal/neonatal outcomes were considered. Policy in Pescara hospital is based on cultural support of teamworks working in labor ward. Florence policy is based on availability of two teamworks previously skilled for twin vaginal delivery

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

In the period 2017-2020 before starting of simulator training for obstetrics emergencies, twin birth were collected. Incidence of vaginal birth and incidence of maternal adverse outcome (such as PPH) and fetal/neonatal adverse outcome (such as NICU stay) were recorded. The same outcomes were collected in twin deliveries after 34 wks in the period 2021-2024. Similarly in San Giovanni di Dio Hospital Florence they started this protocol in July 2022. The retrospective data enrollement identified the period January 2020-June 2022 and July 2022-December 2024. Teamworks in Pescara Hospital were supported by continous formation for retaining skills on vaginal birth particularly twin vaginal deliveries. In Florence Hospital two teamworks were supporting patients wondering for a vaginal birth and in the meantime positive results were collected in labor ward

Study Type

Observational

Enrollment (Actual)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • FI
      • Florence, FI, Italy, 50143
        • San Giovanni di Dio Hospital
    • PE
      • Pescara, PE, Italy, 65121
        • Santo Spirito Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Pregnancies after 34 weeks' gestation elegible for vaginal birth

Description

Inclusion Criteria:

  • twin pregnancies after 34 weeks

Exclusion Criteria:

  • multiple pregnancies monochorionic monoamniotic pregnancies gestational age before 34 weeks completed cesarean indication unrelated to pregnancy (placenta previa, maternal diseases, etc)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Before
twin deliveries after 34 wks 2017 january-2020 December (Pescara), and 2020 January-2022 June (Florence)
Incidence of cesarean sections in the two periods, Rate of adverse outcomes within vaginal and cesarean deliveries
After
twin deliveries after 34 wks January 2021-december 2024 (Pescara), and July 2022-December 2024
Incidence of cesarean sections in the two periods, Rate of adverse outcomes within vaginal and cesarean deliveries

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vaginal birth
Time Frame: 4 years (Pescara)- 2.5 years (Florence)
Rate of vaginal birth
4 years (Pescara)- 2.5 years (Florence)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal outcomes
Time Frame: 4 years (Pescara)- 2.5 years (Florence)
Rate of PPH within cesarean section and vaginal deliveries
4 years (Pescara)- 2.5 years (Florence)
Fetal Neonatal outcomes
Time Frame: 4 years (Pescara)- 2.5 years (Florence)
Incidence of overall fetal neonatal outcomes (such as NICU stay, RDS, HPE, etc)
4 years (Pescara)- 2.5 years (Florence)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Claudio Celentano, MD, University d'Annunzio Chieti Pescara

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

December 31, 2020

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

October 3, 2024

First Submitted That Met QC Criteria

October 3, 2024

First Posted (Actual)

October 8, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 9, 2025

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ObGynEASC007

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cearean Section Rate

Clinical Trials on cesarean section rate

Subscribe